The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.
Ma MH, Yang HH, Parker K, Manyak S, Friedman JM, Altamirano C, Wu ZQ, Borad MJ, Frantzen M, Roussos E, Neeser J, Mikail A, Adams J, Sjak-Shie N, Vescio RA, Berenson JR.
Ma MH, et al. Among authors: friedman jm.
Clin Cancer Res. 2003 Mar;9(3):1136-44.
Clin Cancer Res. 2003.
PMID: 12631619